Cormedix Stock Price Prediction
| CRMD Stock | USD 9.96 0.37 3.58% |
Oversold Vs Overbought
63
Oversold | Overbought |
EPS Estimate Next Quarter (0.01) | EPS Estimate Current Year (0.52) | EPS Estimate Next Year 0.45 | Wall Street Target Price 14.25 | EPS Estimate Current Quarter (0.10) |
Using CorMedix hype-based prediction, you can estimate the value of CorMedix from the perspective of CorMedix response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CorMedix to buy its stock at a price that has no basis in reality. In that case, they are not buying CorMedix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CorMedix after-hype prediction price | USD 10.02 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CorMedix |
CorMedix After-Hype Price Prediction Density Analysis
As far as predicting the price of CorMedix at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CorMedix or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CorMedix, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CorMedix Estimiated After-Hype Price Volatility
In the context of predicting CorMedix's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CorMedix's historical news coverage. CorMedix's after-hype downside and upside margins for the prediction period are 5.20 and 14.84, respectively. We have considered CorMedix's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CorMedix is slightly risky at this time. Analysis and calculation of next after-hype price of CorMedix is based on 3 months time horizon.
CorMedix Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CorMedix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CorMedix backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CorMedix, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.87 | 4.82 | 0.06 | 0.10 | 9 Events / Month | 18 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
9.96 | 10.02 | 0.60 |
|
CorMedix Hype Timeline
CorMedix is currently traded for 9.96. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of 0.1. CorMedix is expected to increase in value after the next headline, with the price projected to jump to 10.02 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.6%, whereas the daily expected return is currently at 0.87%. The volatility of related hype on CorMedix is about 4347.45%, with the expected price after the next announcement by competition of 10.06. Net Loss for the year was (46.34 M) with profit before overhead, payroll, taxes, and interest of 61.67 K. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out CorMedix Basic Forecasting Models to cross-verify your projections.CorMedix Related Hype Analysis
Having access to credible news sources related to CorMedix's direct competition is more important than ever and may enhance your ability to predict CorMedix's future price movements. Getting to know how CorMedix's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CorMedix may potentially react to the hype associated with one of its peers.
CorMedix Additional Predictive Modules
Most predictive techniques to examine CorMedix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CorMedix using various technical indicators. When you analyze CorMedix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CorMedix Predictive Indicators
The successful prediction of CorMedix stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CorMedix, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CorMedix based on analysis of CorMedix hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CorMedix's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CorMedix's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0202 | 0.0179 | Price To Sales Ratio | 3.0K | 1.6K |
Story Coverage note for CorMedix
The number of cover stories for CorMedix depends on current market conditions and CorMedix's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CorMedix is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CorMedix's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
CorMedix Short Properties
CorMedix's future price predictability will typically decrease when CorMedix's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CorMedix often depends not only on the future outlook of the potential CorMedix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CorMedix's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.9 M | |
| Cash And Short Term Investments | 76 M |
Complementary Tools for CorMedix Stock analysis
When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |